William W. Chin, MD

William W. Chin, MD

William W. Chin, MD

Forum on Healthcare Innovation Faculty Co-Chair
Bertarelli Distinguished Professor of Translational Medical Science and Professor of Medicine, Harvard Medical School

William W. Chin, MD, is the executive vice president for Science and Regulatory Affairs at Pharmaceutical Research and Manufacturers of America (PhRMA) in Washington, D.C., and the Bertarelli Distinguished Professor of Translational Medical Science and Professor of Medicine at Harvard Medical School (HMS). 

As the former executive dean for research at HMS, Dr. Chin simultaneously spearheaded multiple efforts to design and implement the vision for research at HMS, with special emphasis on interdisciplinary and translational research that crossed departmental and institutional boundaries.

Dr. Chin is a Harvard-trained endocrinologist and longstanding faculty member. His career is exemplified in part by his extensive bibliography of nearly 300 papers, chapters, and books, most of which were generated during his 25 years on the Harvard Medical School faculty. During his tenure as a faculty member in the Department of Medicine at Brigham and Women's Hospital, he became chief of the genetics division and a Howard Hughes Medical Institute investigator, advancing to professor of medicine and obstetrics, gynecology, and reproductive biology at HMS.

As a pioneering molecular endocrinologist at HMS, Dr. Chin embraced the early use of emerging DNA technology to make important discoveries regarding the structure, function, and regulation of hormone genes. His investigations often demonstrated a translational research theme, connecting basic laboratory discoveries to their physiologic relevance in animal models and humans.

He has been honored with numerous awards for research, mentorship, and leadership. He is a graduate of Columbia College and Harvard Medical School. Prior to his appointment as executive dean for research at HMS, Dr. Chin was at Eli Lilly and Company, where he had worked for the last decade, most recently as senior vice president for discovery research and clinical investigation.